Aclidinium Bromide: Clinical Benefit in Patients with Moderate to Severe COPD
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Long-acting bronchodilators are the mainstay of pharmacological treatment for patients with chronic obstructive pulmonary disease (COPD). The aim of this review is to provide an overview of the clinical studies evaluating the safety and efficacy of inhaled aclidinium bromide, a novel long-acting anticholinergic bronchodilator, for the treatment of COPD.
Originalsprog | Engelsk |
---|---|
Tidsskrift | The Open Respiratory Medicine Journal |
Vol/bind | 6 |
Sider (fra-til) | 150-4 |
Antal sider | 5 |
ISSN | 1874-3064 |
DOI | |
Status | Udgivet - 2012 |
ID: 48598043